The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol

Overview of attention for article published in Drug Design, Development and Therapy, October 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Citations

dimensions_citation: 70 Dimensions

Readers on

mendeley: 122 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Precision medicine for cholesterol treatment

Grant US-11555066-B2

United States of America

PCSK9 inhibitory polypolypeptides and methods of use

Grant US-11529390-B2

United States of America

Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment

Grant US-11434305-B2

United States of America

Targeting rare human PCSK9 variants for cholesterol treatment

Grant US-10618971-B2

United States of America

Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment

Grant US-10611849-B2

United States of America